Our Approach: Built to Move With You
Working with Syneos Health feels like having an extension of your team. From the first conversation, we focus on your asset, your ways of working and where you want support—building the engagement around you. We move with you, leading with expertise and adapting without losing momentum. We pair deep clinical and commercial expertise with modern technology to power agility that scales to meet complexity.
Our Global Footprint:
25,000+
colleagues
61
countries represented
6
continents served
Over the last 5 years, Syneos Health worked to develop or commercialize:
93%
of novel drugs approved by the FDA
88%
of novel drugs approved by the EMA
Committed teams, deeply invested in your success
In clinical development, consistency keeps studies moving as global complexity increases. By synchronizing standards and accountability, we create stability and sustain momentum, always measuring our success by yours.
Every Syneos Health engagement is led by therapeutic, operational and scientific experts who invest in learning your assets, your team and your goals. We prioritize study team continuity and manage handoff events so that the context, priorities and progress your programs have built carry forward and every team member works from the same foundation. Our technology and data insights keep decisions and communication connected and proactive, creating shared visibility so teams stay aligned and transparency is prioritized from start to finish. When your team and ours are working from the same information at the same time, decisions happen faster and with fewer misalignments.
The same is true as we partner with customers across every stage of commercialization. From strategy through execution, your team and ours work as one, sharing intelligence, pressure-testing decisions and staying aligned as the program evolves. Our approach brings together our combined expertise, powered by predictive technology and insights that sharpen strategy and accelerate results.
Talk to our team
Every Syneos Health partnership starts with a conversation: about your therapy, your team and your goals. We know that when we bring the right people together at the right time, aligned to the same goals, anything is possible.
Meeting you where you are, with agility that scales
Every Syneos Health engagement starts with how you want to operate. Governance cadence, communication style, status reporting formats, escalation paths, and decision-making authority are agreed at kickoff and shaped to your team.
When studies take unexpected turns, we’re already a step ahead. Our teams adapt seamlessly as things evolve—delivering science-led, technology-enabled, predictable execution. We flex without adding friction to keep studies moving and timelines on track. Our services scale to meet your needs, ranging from full-service solutions to an agile FSP partnership model all grounded in rich operational and therapeutic expertise. We have the scale to deliver large phase III studies and the nimble approach required by biotech leadership.
Commercialization capabilities that move together
Commercial programs succeed when all functions stay aligned. We design for regulatory, market access and channel complexity from the outset. Our data and analytics engine choreographs activity across the full commercial pathway, aligning sales, marketing and delivery to create a coordinated system that adapts as the engagement unfolds.
Our scale means we can navigate complexity without slowing down, and our flexibility means we can enter at any point in the commercialization process to deliver results.
Partnering with purpose
Syneos Health teams take ownership of outcomes, not just deliverables. That means surfacing risk early, escalating transparently and pushing back constructively when it serves your program. We share your aspirations—we wouldn’t be here otherwise—and we measure our success by yours.
Commitment shows up in our proactive approach and operational specifics. Risks are flagged with proposed mitigations, not buried in status reports. Difficult conversations — about what’s possible, timeline or strategic pivots — happen in the room with you, not after the fact. When customers describe what working with Syneos Health is like, the word that comes up most often is partner.
The Trusted Process®: Structure where it helps, flexibility where it matters
The Trusted Process® is Syneos Health’s drug development operating model: the framework that gives every engagement clear accountability, quality control and escalation paths. It is structured enough to deliver consistently across programs of any size and flexible enough to be shaped to each customer’s way of working. Within the Trusted Process, customers define the cadence, the communication style and the governance that fits their team.
Different by design
Customers come to us because we’re a partner built around a different premise: that designing a solution around customer needs and goals leads to more successful outcomes for all.
The result is what customers describe as a team that feels like their own, including experts who understand the therapy, the science, the patient population and your business goals; an operating cadence that matches how their team already works; and a commitment to successful, impactful outcomes that goes beyond deliverables.
When customers need assistance across clinical development and into commercialization, our experts are available. But what defines a Syneos Health partnership goes beyond the scope. It is how the team shows up: driven to deliver, proactive in guidance and built to move with you.
Frequently Asked Questions
Working with Syneos Health feels like an extension of the customer’s own team and like working with a proven partner that is driven, decisive and built to move. Each engagement is led by an expert team invested in learning your business, goals and ways of working.
The Syneos Health difference is people-led, adaptive partnership. Syneos Health builds a program around the customer’s team, leading with expertise, acting with agility and pairing a committed team with proactive guidance and market fluency.
To develop a leading commercial strategy, the Syneos Health team combines predictive intelligence, deep commercial expertise and proprietary technology, accelerating performance with the speed to turn opportunity into outcomes.
It means Syneos Health teams operate as an extension of the customer’s organization. Decisions are made with the customer goals at the center, escalation paths are transparent and the team is willing to push back constructively when it serves the program. It’s a collaborative partnership between two passionate teams with shared goals.
Working with Syneos Health feels like an extension of the customer’s own team and like working with a proven partner that is driven, decisive and built to move. Each engagement is led by an Every Syneos Health engagement starts with understanding project and company goals, as well as how the customer expects a project to operate. Communication style, project updates, escalation paths and decision-making authority are agreed at kickoff and shaped to the customer’s preferences.
Changes are surfaced early, costed transparently and routed through governance the customer helped design. Because team composition is consistent and embedded, decisions on amendments, site changes or strategic pivots can move quickly without losing institutional knowledge of the program. Flexibility is built into the operating model rather than negotiated as an exception.
Working with Syneos Health feels likYes. The same people-led approach applies across customer size: the engagement model, team composition and operating cadence are tailored to the program. Biotech customers access dedicated teams structured for asset-focused engagement; larger customers access the same adaptive model at enterprise scale.
Contact the Syneos Health team here. Initial conversations focus on understanding the customer’s asset, team and goals and matching the right experts and engagement model to the program. There is no off-the-shelf package.
AI is accelerating clinical trials by improving study design, patient enrollment and data quality. Machine learning models analyze historical data to optimize protocols and identify the best sites and patient populations. AI-powered tools enhance recruitment through precision targeting and streamline site activation and feasibility. During trials, automated data monitoring and real-time analytics help detect issues earlier, reduce cycle times and increase efficiency. At Syneos Health, we use technology, predictive modeling and proprietary methodologies to help increase study confidence, minimize risk and enable smarter, real-time decisions so that you’re ready for what’s next.
Syneos Health uses AI to sharpen commercial performance across the entire customer engagement lifecycle, from launch planning through field execution, including our multi-year partnership with Microsoft designed to elevate the commercial performance of biopharmaceutical organizations. Our roster of purpose-built commercial platforms include Kinetic (healthcare business intelligence), Evolvics (predictive omnichannel media), AnswerSuite (syndicated biopharmaceutical data), MODAL (AI-powered learning solutions), and AI MSL solutions that help medical and field teams engage healthcare professionals more efficiently.
